手机扫码接着看

splinterlandsdappradar| Hengrui Pharmaceutical: Plans to repurchase shares between 600 million yuan and 1.2 billion yuan

Author:editor|Category:Tourism

News summary

[Hengrui Pharmaceutical: Plans to repurchase shares from 600 million yuan to 1.2 billion yuan] Securities Times e Company NewssplinterlandsdappradarHengrui Pharmaceutical (600276) announced on the evening of May 15 that the company plans to repurchase shares through centralized bidding transactions for employee stock ownership plans. repurchase of sharessplinterlandsdappradarThe total amount of funds is no less than 600 million yuan, no more than 12splinterlandsdappradar.splinterlandsdappradar..

splinterlandsdappradar| Hengrui Pharmaceutical: Plans to repurchase shares between 600 million yuan and 1.2 billion yuan

Newsletter text

[Hengrui Pharmaceutical: Plans to repurchase shares between RMB 600 million and RMB 1.2 billion] Securities Times e Company News, Hengrui Pharmaceutical (600276) announced on the evening of May 15 that the company plans to repurchase shares through centralized bidding transactions for employee stock ownership plan. The total amount of funds for repurchase of shares shall be no less than 600 million yuan, no more than 1.2 billion yuan, and the repurchase price shall not exceed 67.38 yuan/share.

15 05

2024-05-15 21:06:47

浏览18
Back to
Category
Back to
Homepage
pointblankarcade| Figure: Financial fraud will cause global losses of US$485.6 billion in 2023, equivalent to Singapore's GDP pennslammer36500hs| ATFX currency market: U.S. CPI data hits in April, market expectations will be lower than previous values